CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +7,866 | $25.01 | $197K | 62,511 |
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −7,866 | $37.69 | $296K | 54,645 |
| 2026-10-26 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Stock options (right to buy) 10b5-1 | −7,866 | 16,275 | ||
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +500 | $25.01 | $13K | 55,145 |
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −500 | $37.52 | $19K | 54,645 |
| 2026-10-22 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Stock options (right to buy) 10b5-1 | −500 | 24,141 | ||
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +1,489 | $25.01 | $37K | 56,134 |
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,489 | $37.53 | $56K | 54,645 |
| 2026-10-21 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Stock options (right to buy) 10b5-1 | −1,489 | 24,641 | ||
| 2026-08-04 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −30,000 | $30.48 | $914K | 54,645 |
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +8,375 | 88,652 | ||
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −4,007 | $37.56 | $151K | 84,645 |
| 2026-07-01 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Restricted stock units 10b5-1 | −8,375 | 0 | ||
| 2026-06-18 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Performance share units | −3,000 | 9,000 | ||
| 2026-06-18 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units | +3,000 | 3,000 | ||
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +8,500 | 83,217 | ||
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −2,940 | $34.71 | $102K | 80,277 |
| 2026-04-02 | Gheuens Sarah Chief Medical Officer | Exercise or conversion · Performance share units 10b5-1 | −8,500 | 8,500 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Exercise or conversion 10b5-1 | +4,000 | 68,795 | ||
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 67,608 |
Page 1 of 6 · 112 trades